Neoadjuvant Conformal Radiotherapy and Concomitant CPT-11 and EGFR Inhibition With Cetuximab in Patients With Rectal Cancer Phase I Study.
Phase of Trial: Phase I
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Irinotecan (Primary) ; Cetuximab
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 04 Nov 2006 New trial record.